Semaglutide and the Future of Dementia Prevention: A Promising Avenue? Recent research is offering a glimmer of hope in the fight against Alzheimer’s disease and other forms of dementia. A new study published in the Journal of Alzheimer’s Disease suggests that semaglutide, a medication commonly used to treat type 2 diabetes, may significantly reduce the … Read more
A New Dawn for Kidney Health: Combining Therapies to Combat Chronic Kidney Disease and Type 2 Diabetes The landscape of chronic kidney disease (CKD) and type 2 diabetes (T2D) treatment is undergoing a radical shift. Recent findings from the CONFIDENCE trial, presented at the European Renal Association (ERA) Congress 2025 and published in the New … Read more
The Future of Diabetes Treatment: Innovations and Strategic Directions Recent developments in diabetes treatment highlight the dynamic landscape of pharmaceutical interventions, with new drugs like sotagliflozin shaping future therapeutic approaches. Though not approved specifically for glucose-lowering purposes, its significant impact on A1c and body weight reduction, even in cardiovascular patients, cannot be overlooked. Sotagliflozin: A … Read more
Future Trends in Diabetes Management and Patient Education Every year, over 1.4 million people receive a new diabetes diagnosis, necessitating a nuanced approach to patient education and disease management. As these conversations evolve, healthcare providers are increasingly embracing personalized strategies that respect individual patient understanding and motivation. Here, we explore future trends in diabetes management … Read more
The Hidden Risks of Combining SGLT2 Inhibitors with a Keto Diet Recent cases have brought to light an unexpected danger when patients using sodium-glucose cotransporter-2 (SGLT2) inhibitors adopt a keto diet. Understanding and awareness of this risk are paramount as the prevalence of SGLT2 inhibitors and ketogenic diets continue to rise. The Synergistic Threat of … Read more
How diabetes-treatment/” title=”Hope for Over 800 Million: Breakthrough in … Treatment”>GLP-1 Receptor Agonists Are Shaping the Future of Surgery The rising popularity of glucagon-like peptide 1 (GLP-1) receptor agonists has put the spotlight on their perioperative effects, sparking considerable interest at the American Academy of Orthopaedic Surgeons 2025 Annual Meeting. Researchers are keen to understand … Read more
The Future of Automated Insulin Delivery in Type 2 Diabetes Management Revolutionizing Diabetes Care with AID Technology The recent success of the Tandem Diabetes Care’s next-generation Control-IQ+ algorithm is a game-changer in managing insulin-treated type 2 diabetes (T2D). This cutting-edge technology has demonstrated significant reductions in A1c and hyperglycemia without increasing hypoglycemia risks, marking a … Read more
The Role of SGLT2 Inhibitors in Type 2 Diabetes Management In a recent study published in JAMA Internal Medicine, researchers found no significant differences in kidney outcomes between patients with type 2 diabetes (T2D) treated with the SGLT2 inhibitors empagliflozin and dapagliflozin. Both drugs are commonly used to manage cardiovascular and kidney outcomes in T2D … Read more
Unlocking the Future of GLP-1 Receptor Agonists: Insights and Trends A groundbreaking study analyzing over two million diabetes patients reveals both the wide-ranging benefits and potential risks of glucagon-like peptide 1 receptor agonists (GLP-1 RAs). This pioneering research, published in Nature Medicine, provides an extensive outcomes map, setting the stage for deeper exploration into these … Read more
The Future of Personalized Obesity Management PALO ALTO, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) – Digbi Health’s cutting-edge precision biology-based approach is revolutionizing how obesity is managed. By introducing enhancements to their flagship GLP-Compass test, they’re setting new benchmarks in personalized healthcare. This innovative solution not only tailors treatment but also uses a data-driven methodology … Read more